This inventor holds 1 USPTO granted patent. Top assignee: Anji Bruno, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jeanmarie Dean Guenot: Innovator in Immunotherapy
Introduction
Jeanmarie Dean Guenot is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of cancers such as acute myeloid leukemia (AML). His innovative work has led to the development of unique binding proteins that target specific cancer cells.
Latest Patents
Jeanmarie holds 1 patent for his invention titled "Methods of using bispecific CD33 and CD3 binding proteins." This patent describes binding proteins that specifically bind to human CD33, focusing on bispecific binding proteins that interact with both human CD33 and human CD3. The invention also includes bispecific tandem diabodies that bind to CD33, which are intended for use in immunotherapy for CD33-related cancers and diseases.
Career Highlights
Throughout his career, Jeanmarie has been dedicated to advancing medical science through innovative research and development. His work has the potential to significantly impact the treatment landscape for various cancers, providing new hope for patients.
Collaborations
Jeanmarie has collaborated with esteemed colleagues in the field, including Luke Evnin and Lori Kunkel. Their combined expertise has contributed to the advancement of immunotherapy research and development.
Conclusion
Jeanmarie Dean Guenot is a pioneering inventor whose work in immunotherapy is paving the way for new treatment options for cancer patients. His innovative approaches and collaborations highlight the importance of research in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile